News about Market

Kilitch Drugs to Raise INR 49.92 Cr via Rights Issue to Fund Greenfield Expansion and Growth Plans

At its recent board meeting, the company approved the issuance of 1,398,463 fully paid-up equity shares at INR 357 per share (face value INR 10 and premium of INR 347). The entitlement ratio for eligible shareholders is 2 rights equity shares for every 23 fully paid equity shares held.

Market | 24/07/2025 | By Darshana |  273

Syngene Reports 14.5% YoY Growth in Q1 Net Profit, Driven by Strong Research Services Momentum

Operational revenue grew by 10.7% to INR 874.5 crore from INR 789.7 crore in Q1 FY25. EBITDA for the quarter rose 19% to INR 224 crore, compared to INR 188 crore last year. The EBITDA margin improved to 25%, up from 23% a year ago.

Market | 24/07/2025 | By Darshana |  284

DGFT Extends Deadline for Pharma-Grade Sugar Export Quota Applications to July 31

Exporters must apply online via DGFT’s e-Commerce portal under the “Non-SCOMET Restricted Items” category. Previously, applications were to be submitted between June 20 and July 20, 2025.

Market | 23/07/2025 | By Darshana |  255

Torrent Pharma Seeks CCI Nod for INR 19,500 Crore Acquisition of JB Chemicals

According to the filing, the transaction involves acquisition of shares in JB Chemicals, followed by the amalgamation of the target company with Torrent Pharmaceuticals.

Market | 18/07/2025 | By Darshana |  384

Novartis Reports Double-Digit Sales Growth In Q2, Raises Full-Year Guidance

Novartis has reported a robust financial performance for the second quarter of 2025, with net sales reaching USD 14.1 billion, up 12 percent year-on-year.

Market | 17/07/2025 | By Dineshwori |  1241

India's Pharma Exports Up Nearly 6 Percent in June; Total Exports Hit USD 68 Billion

Alongside drugs and pharmaceuticals, major drivers of India’s merchandise export growth in June 2025 included electronic goods, engineering goods, marine products, and meat, dairy, and poultry products.

Market | 16/07/2025 | By Dineshwori |  1014

Indian Pharma Faces Diverging Fortunes Amid Growth in CDMO and API Segments

Operational gains were seen in EBITDA margin expansion, aided by improved product mix and execution in regulated markets. ROCE, however, remained muted due to under-utilised greenfield facilities and acquisition-led debt. Companies are rationalising R&D investments to monetise existing ANDA filings rather than prioritising fresh approvals.

Market | 16/07/2025 | By Darshana |  680

Biologics and Biosimilars Market: APAC Poised for Rapid Growth Driven by Rising Investments and Patient Pool

The global biologics and biosimilars market is expected to reach approximately USD 600 billion by 2032, expanding at a compound annual growth rate (CAGR) of around 6.33 percent during the forecast period.

Market | 15/07/2025 | By Dineshwori |  173

India Eyes 1 Trillion USD Pharma Exports by 2030, Biosimilars to Lead Growth Surge

As reported by The Economic Times, Pharmexcil Chairman Namit Joshi projected that India’s biosimilars segment could exceed 60 billion USD in exports by 2030—accounting for nearly half of the estimated 120–130 billion USD in total pharma exports.

Market | 15/07/2025 | By Darshana |  554

Global Topical Antibiotics Market Projected to Surpass USD 11 Billion by 2032

The global topical antibiotics market, valued at USD 6.42 billion in 2024, is expected to reach nearly USD 11.20 billion by 2032.

Market | 14/07/2025 | By Dineshwori |  265